Closing Figures: Viking Therapeutics Inc (VKTX)’s Positive Finish at 56.38, Up 0.70

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $55.99 in the prior trading day, Viking Therapeutics Inc (NASDAQ: VKTX) closed at $56.38, up 0.70%. In other words, the price has increased by $0.70 from its previous closing price. On the day, 1.85 million shares were traded. VKTX stock price reached its highest trading level at $57.3054 during the session, while it also had its lowest trading level at $54.8479.


Our goal is to gain a better understanding of VKTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.48 and its Current Ratio is at 29.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on May 16, 2024, Upgraded its rating to Strong Buy and sets its target price to $116 from $115 previously.

On March 26, 2024, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $116 to $138.

On March 07, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $110.Jefferies initiated its Buy rating on March 07, 2024, with a $110 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 03 ’24 when ZANTE GREG sold 66,756 shares for $74.69 per share. The transaction valued at 4,986,008 led to the insider holds 174,854 shares of the business.

Mancini Marianna sold 281,425 shares of VKTX for $22,136,474 on May 01 ’24. The Chief Operating Officer now owns 348,508 shares after completing the transaction at $78.66 per share. On Feb 09 ’24, another insider, Lian Brian, who serves as the President & CEO of the company, sold 45,000 shares for $29.90 each. As a result, the insider received 1,345,500 and left with 2,139,882 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 6216909824 and an Enterprise Value of 5255126528.

Stock Price History:

Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is -19.20%, while the 200-Day Moving Average is calculated to be 54.13%.

Shares Statistics:

The stock has traded on average 3.92M shares per day over the past 3-months and 3456350 shares per day over the last 10 days, according to various share statistics. A total of 110.27M shares are outstanding, with a floating share count of 102.43M. Insiders hold about 7.11% of the company’s shares, while institutions hold 72.77% stake in the company. Shares short for VKTX as of 1715731200 were 12174916 with a Short Ratio of 3.11, compared to 1713139200 on 11147825. Therefore, it implies a Short% of Shares Outstanding of 12174916 and a Short% of Float of 14.879999999999999.

Most Popular